The United States Patent and Trademark Office (USPTO) has published an intent-to-use trademark application (TM99492708) for the mark 'PR PDRN (POLYDEOXYRIBONUCLEOTIDE SODIUM) 10 G'. The application, filed on November 12, 2025, seeks to register the mark for a range of pharmaceutical preparations for skin care, including medicated creams, ointments for dermatological use, anti-itch ointments, and antiseptic ointments.

This filing represents a new trademark application and does not impose any immediate compliance obligations. However, it signals potential market entry or brand expansion for the applicant in the pharmaceutical and dermatological sectors. Companies operating in these areas should be aware of this new mark as it may affect future branding and product naming strategies.